Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2020 11:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Announces FDA Orphan Drug Designation for RHB-204 for the Treatment of NTM Infections

RHB-204 Phase 3 study in pulmonary NTM infections is planned to be initiated in the coming weeks--Orphan Drug Designation, along with RHB-204’s FDA QIDP priority designation, will extend U.S....
April 11, 2016 07:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Launches QUINSAIR™ in Europe

NOVATO, Calif., April 11, 2016 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its first commercial sale of QUINSAIR™ (levofloxacin inhalation solution) in Germany and...
October 05, 2015 07:05 ET | Source: Raptor Pharmaceutical Inc

Raptor Pharmaceutical Completes Acquisition of Quinsair(TM)

NOVATO, Calif., Oct. 5, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has completed the acquisition of Quinsair™ (levofloxacin inhalation solution)...
September 22, 2015 08:00 ET | Source: Insmed, Inc.

Insmed Announces Upcoming Data Presentations at ERS 2015

BRIDGEWATER, N.J. , Sept. 22, 2015 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the needs of patients with rare diseases today reported two...